Telix Pharmaceuticals Limited (TLX)

NASDAQ: TLX · Real-Time Price · USD

12.33

+0.36 (3.01%)

At close: Aug 13, 2026, 4:00 PM EDT

11.87

-0.46 (-3.73%)

Pre-market: Aug 14, 2026, 4:01 AM EDT

Telix Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	4,013	2,537	5,155	-	-	-
Market Cap Growth	8.81%	-50.78%	-	-	-	-
Enterprise Value	4,358	2,863	5,075	0	0	0
Last Close Price	12.33	7.49	15.40	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	153.03	-	-	-
PS Ratio	4.99	3.16	9.98	-	-	-
PB Ratio	9.66	6.11	14.61	-	-	-
P/TBV Ratio	-	-	54.22	-	-	-
P/FCF Ratio	-	-	112.40	-	-	-
P/OCF Ratio	-	-	93.76	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.42	3.56	9.82	-	-	-
EV/EBITDA Ratio	85.14	55.93	83.94	-	-	-
EV/EBIT Ratio	146.35	96.14	91.98	-	-	-
EV/FCF Ratio	-	-	110.65	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	1.08	1.08	0.98	0.11	0.12	0.88
Debt / EBITDA Ratio	9.13	9.13	5.96	0.78	-	-
Debt / FCF Ratio	-	-	7.85	0.53	-	-
Net Debt / Equity Ratio	0.78	0.78	-0.23	-0.71	-1.32	-9.03
Net Debt / EBITDA Ratio	6.35	6.35	-1.32	-4.75	1.22	0.48
Net Debt / FCF Ratio	-5.40	-5.40	-1.74	-3.24	1.49	0.32
Asset Turnover	0.76	0.76	0.85	1.48	0.86	0.05
Inventory Turnover	12.43	12.43	10.19	14.06	10.71	1.24
Quick Ratio	1.17	1.17	2.57	1.14	1.82	1.09
Current Ratio	1.43	1.43	2.78	1.41	2.02	1.25
Return on Equity (ROE)	-1.85%	-1.85%	14.83%	5.40%	-252.89%	-187.51%
Return on Assets (ROA)	3.83%	3.83%	8.06%	7.93%	-52.07%	-33.21%
Return on Invested Capital (ROIC)	5.44%	7.95%	32.41%	303.58%	-	-
Return on Capital Employed (ROCE)	3.57%	3.57%	12.27%	7.87%	-74.58%	-42.19%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-	-	0.65%	-	-	-
FCF Yield	-	-	0.89%	-	-	-
Buyback Yield / Dilution	2.12%	-1.21%	-3.40%	-2.33%	-10.97%	-
Total Shareholder Return	2.12%	-1.21%	-3.40%	-2.33%	-10.97%	-

SEC Filings: 10-K · 10-Q